Reimbursed with a limitationOriginator productATC C10BA06

Ezetimib Rosuvastatin axapharm

Ezetimib Rosuvastatin axapharm is an originator product from axapharm ag and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 35.75 to CHF 77.50 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
axapharm ag
ATC code
C10BA06
IT group
07.12 Blutlipidsenkende Mittel
Active substances
Ezetimibum, Rosuvastatinum
Preparation type
Originator product
On the SL since
01/03/2024
Last price change
01/03/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Ezetimib Rosuvastatin axapharm Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 10/10 mgBlist 30 StkCHF 17.80CHF 35.7501/03/2024B7680690040017
Filmtabl 10/10 mgBlist 90 StkCHF 50.94CHF 71.8001/03/2024B7680690040024
Filmtabl 10/20 mgBlist 30 StkCHF 19.56CHF 37.7001/03/2024B7680690040031
Filmtabl 10/20 mgBlist 90 StkCHF 56.16CHF 77.5001/03/2024B7680690040048

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/03/2024

EZETIMIB ROSUVASTATIN AXAPHARM wird als Ersatztherapie bei erwachsenen Patienten vergütet, die bereits Ezetimib und Rosuvastatin als separate Tabletten in der gleichen Dosierungsstärke erhalten und die Kriterien entsprechend der Limitierungen der Ezetimib- und Rosuvastatin-Monopräparate erfüllen.

More preparations in this group

FAQ

Is Ezetimib Rosuvastatin axapharm covered by Swiss health insurance?

Yes, but only under conditions. Ezetimib Rosuvastatin axapharm is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Ezetimib Rosuvastatin axapharm cost in Switzerland?

The public price is the maximum price set by the FOPH and for Ezetimib Rosuvastatin axapharm ranges from CHF 35.75 to CHF 77.50 per pack. The ex-factory price ranges from CHF 17.80 to CHF 56.16. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com